Investor Relations

 

Transcat (Nasdaq:TRNS) has been a leader in the test and measurement industry for over 40 years. We strive to differentiate ourselves and build barriers to competitive entry by offering the best products, delivering high quality calibration and repair services, and integrating those products and services. We work diligently to create lasting value for our shareholders.

Strategy

Our strategy is to continue to grow our business through a blend of organic revenue growth and acquisitions. We leverage the complementary nature of our operating segments in ways that add value for all customers who select Transcat as their source for test and measurement equipment and/or calibration and laboratory instrument services. We believe our combined Service and Distribution segment offerings, experience, technical expertise and quality-oriented, integrity-based approach create a unique and compelling value proposition for our customers. We strive to differentiate ourselves within the markets we serve and build barriers to competitive entry by offering a broad range of the best products and services, and integrating those products and services to benefit our customers’ operations.

Annual Reports

Get access to Transcat’s annual reports, read meeting transcripts and view annual report presentations

Earnings Releases

View Transcat’s earnings releases, listen to presentation webcasts or view the presentation slides

Corporate Governance

View Transcat's corporate governance guidelines, board of directors, executive officers and senior management

Recent Company News

Transcat, Inc. Increases Shelf Registration to $75 million

ROCHESTER, NY, November 17, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has filed a new shelf registration statement on Form S-3 with the United States Securities and Exchange Commission (“SEC”) to replace its previous shelf registration statement, which expires on December 17, 2020. The registration statement was filed on November 17, 2020 and will become effective upon successful review by the SEC.

Transcat Appoints Mark A. Doheny as Chief Financial Officer

ROCHESTER, NY, November 10, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced the appointment of Mark A. Doheny as Chief Financial Officer. Mr. Doheny succeeds Michael J. Tschiderer, who will provide support as needed until his retirement from Transcat at the end of the calendar year.

Transcat Reports Record Second Quarter Operating Income of $3.1 Million on Strong Service Gross Margin

  • Consolidated gross margin up 260 basis points to 27.6% driven by impressive Service segment gross margin of 32.2%
  • Total revenue of $41.6 million consistent with prior-year period in a challenging market environment; Service segment achieved 46th consecutive quarter of year-over-year growth
  • Quarterly cash from operations of $8.5 million; debt reduced by $5.8 million

For further information, please contact:

Deborah Pawlowski
Kei Advisors
7606 Transit Road
Suite 300
Buffalo, NY 14221
Phone: 716.843.3908
Email: dpawlowski@keiadvisors.com

Mark A. Doheny
CFO
35 Vantage Point Drive
Rochester, NY 14624
Phone: 585.714.3617
Email: mark.doheny@transcat.com